SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-17-000246
Filing Date
2017-08-01
Accepted
2017-08-01 07:49:22
Documents
12
Period of Report
2017-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnbt07317form8k.htm 8-K 22660
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 1089364
3 EXHIBIT 99.1 ex99_1.htm EX-99.1 16617
4 GRAPHIC image_015.gif GRAPHIC 3285
5 GRAPHIC image_008.gif GRAPHIC 109
6 GRAPHIC image_009.gif GRAPHIC 6923
7 GRAPHIC image_008.jpg GRAPHIC 1059
8 GRAPHIC image_010.gif GRAPHIC 1043
9 GRAPHIC image_011.gif GRAPHIC 79
10 GRAPHIC image_012.gif GRAPHIC 73
11 GRAPHIC image_016.gif GRAPHIC 27186
12 GRAPHIC image_010.jpg GRAPHIC 17285
  Complete submission text file 0001607062-17-000246.txt   1209259
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0320
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 17994998
SIC: 2834 Pharmaceutical Preparations